Submission for OMB Review; 30-Day Comment Request, 5550-5551 [2024-01698]
Download as PDF
<![CDATA[
ddrumheller on DSK120RN23PROD with NOTICES1
5550
Federal Register / Vol. 89, No. 19 / Monday, January 29, 2024 / Notices
were realigned to their respective
divisions.
The OPQ retitled four of its suboffices
and retitled the majority of its divisions.
The OPQ will establish the Office of
Quality Assurance and within it
established the Quality Assurance Staff,
Learning and Professional Staff, and the
Project Management Staff.
FDA, CDER, OPQ has been
restructured as follows:
DCDL. ORGANIZATION. The Office
of Pharmaceutical Quality is headed by
the Director of Pharmaceutical Quality
and includes the following
organizational units:
Office of Pharmaceutical Quality
(DCDL)
Office of Product Quality Assessment I
(DCDLH)
Division of Product Quality
Assessment I (DCDLHA)
Division of Product Quality
Assessment II (DCDLHB)
Division of Product Quality
Assessment III (DCDLHC)
Division of Product Quality
Assessment IV (DCDLHD)
Division of Product Quality
Assessment V (DCDLHE)
Division of Product Quality
Assessment VI (DCDLHF)
Office of Product Quality Assessment II
(DCDLB)
Division of Product Quality
Assessment VII (DCDLBA)
Division of Product Quality
Assessment VIII (DCDLBB)
Division of Product Quality
Assessment IX (DCDLBC)
Division of Product Quality
Assessment X (DCDLBD)
Division of Product Quality
Assessment XI (DCDLBE)
Division of Product Quality
Assessment XII (DCDLBF)
Office of Product Quality Assessment III
(DCDLA)
Division of Product Quality
Assessment XIII (DCDLAA)
Division of Product Quality
Assessment XIV (DCDLAB)
Division of Product Quality
Assessment XV (DCDLAC)
Division of Product Quality
Assessment XVI (DCDLAD)
Division of Product Quality
Assessment XVII (DCDLAE)
Division of Product Quality
Assessment XVIII (DCDLAF)
Division of Product Quality
Assessment XIX (DCDLAG)
Office of Pharmaceutical Manufacturing
Assessment (DCDLD)
Division of Pharmaceutical
Manufacturing Assessment I
(DCDLDA)
Division of Pharmaceutical
VerDate Sep<11>2014
18:33 Jan 26, 2024
Jkt 262001
Manufacturing Assessment II
(DCDLDB)
Division of Pharmaceutical
Manufacturing Assessment III
(DCDLDC)
Division of Pharmaceutical
Manufacturing Assessment IV
(DCDLDD)
Division of Pharmaceutical
Manufacturing Assessment V
(DCDLDE)
Division of Pharmaceutical
Manufacturing Assessment VI
(DCDLDF)
Office of Program and Regulatory
Operations (DCDLG)
Division of Regulatory & Business
Process Management I (DCDLGA)
Division of Regulatory & Business
Process Management II (DCDLGB)
Division of Regulatory & Business
Process Management III (DCDLGC)
Division of Regulatory & Business
Process Management IV (DCDLGD)
Office of Pharmaceutical Quality
Research (DCDLF)
Division of Pharmaceutical Quality
Research I (DCDLFA)
Division of Pharmaceutical Quality
Research II (DCDLFB)
Division of Pharmaceutical Quality
Research III (DCDLFC)
Division of Pharmaceutical Quality
Research IV (DCDLFD)
Division of Pharmaceutical Quality
Research V (DCDLFE)
Division of Pharmaceutical Quality
Research VI (DCDLFF)
Office of Policy for Pharmaceutical
Quality (DCDLC)
Compendial Operations and
Standards Staff (DCDLCA)
Division of Regulations and Guidance
(DCDLCB)
Division of Internal Policy and
Communication (DCDLCC)
Division of Editorial and Project
Management (DCDLCD)
Office of Quality Assurance (DCDLJ)
Quality Assurance Staff (DCDLJ1)
Learning and Professional
Development Staff (DCDLJ2)
Enterprise Project Management Staff
(DCDLJ3)
Office of Quality Surveillance (DCDLE)
Division of Quality Intelligence I
(DCDLEB)
Division of Quality Intelligence II
(DCDLEC)
Division of Quality Intelligence III
(DCDLED)
Office of Administrative Operations
(DCDLI)
Administrative Analysis Staff
(DCDLI1)
Administrative Operations Staff 1
(DCDLI2)
Administrative Operations Staff 2
(DCDLI3)
PO 00000
Frm 00071
Fmt 4703
Sfmt 4703
Administrative Operations Staff 3
(DCDLI4)
Administrative Operations Staff 4
(DCDLI5)
Financial Services Staff (DCDLI6)
II. Delegations of Authority
Pending further delegation, directives,
or orders by the Commissioner of Food
and Drugs, all delegations and
redelegations of authority made to
officials and employees of affected
organizational components will
continue in them or their successors
pending further redelegations, provided
they are consistent with this
reorganization.
III. Electronic Access
This reorganization is reflected in
FDA’s Staff Manual Guide (SMG).
Persons interested in seeing the
complete SMG can find it on FDA’s
website at: https://www.fda.gov/
AboutFDA/ReportsManualsForms/
StaffManualGuides/default.htm.
(Authority: 44 U.S.C. 3101).
Xavier Becerra,
Secretary of Health and Human Services.
[FR Doc. 2024–01613 Filed 1–26–24; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Submission for OMB Review; 30-Day
Comment Request
Collection of Grants and Contracts
Data the Historically Black Colleges and
Universities (HBCUs) and Small
Businesses May Be Interested in
Pursuing (Office of the Director)
AGENCY: National Institutes of Health,
HHS.
ACTION: Notice.
In compliance with the
Paperwork Reduction Act of 1995, the
National Institutes of Health (NIH),
Office of the Director, Office of
Acquisitions and Logistics Management
(OALM), Small Business Program Office
(SBPO), has submitted to the Office of
Management and Budget (OMB) a
request for review and approval of the
information collection listed below.
DATES: Comments regarding this
information collection are best assured
of having their full effect if received
within 30-days of the date of this
publication.
SUMMARY:
Written comments and
recommendations for the proposed
information collection should be sent
ADDRESSES:
E:\FR\FM\29JAN1.SGM
29JAN1
5551
Federal Register / Vol. 89, No. 19 / Monday, January 29, 2024 / Notices
within 30 days of publication of this
notice to www.reginfo.gov/public/do/
PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function.
To
request more information on the
proposed project or to obtain a copy of
the data collection plans and
instruments, contact: Keondra Watts,
Program Analyst, NIH, Office of the
Director, Office of Acquisitions and
Logistics Management, Small Business
Program Office, 6701 Rockledge Dr.,
Bethesda, MD 20892–7786, or call nontoll-free number (301) 443–8722 or
Email your request, including your
address to: Keondra.Watts@nih.gov.
FOR FURTHER INFORMATION CONTACT:
This
proposed information collection was
previously published in the Federal
Register on October 27, 2023, pages
73864–73865 (88 FR 73864) and
allowed 60 days for public comment. No
public comments were received. The
purpose of this notice is to allow an
additional 30 days for public comment.
SUPPLEMENTARY INFORMATION:
Promote Excellence and Innovation
(PEI) of HBCUs. This Executive Order
mandates agencies to assist in
strengthening HBCUs’ ability for
equitable participation in federal
programs and explore new ways to
improve the relationship between the
federal government and HBCUs. This
initiative will establish how each
agency intends to increase the capacity
of HBCUs to compete effectively for
grants and contracts.
The PEI is a comprehensive plan to
increase the capacity of HBCUs as they
pursue funding opportunities at the
NIH. The PEI provides a platform to
increase transparency between HBCUs
and the NIH by promoting outreach
events and training opportunities and
providing technical assistance.
Currently, there are six HBCU
participants and each selected a
minimum of one small business teaming
partner to pursue NIH funding
opportunities with.
OMB approval is requested for 3
years. There are no costs to respondents
other than their time. The total
estimated annualized burden hours are
883.
The National Institutes of Health
(NIH), Office of the Director, Office of
Acquisitions and Logistics Management,
Small Business Program Office, may not
conduct or sponsor, and the respondent
is not required to respond to any
information collection that has been
extended, revised, or implemented on or
after January 31, 2024, unless it displays
a currently valid Office of Management
and Budget (OMB) control number.
In compliance with Section
3507(a)(1)(D) of the Paperwork
Reduction Act of 1995, NIH has
submitted to OMB a request for review
and approval of the information
collection listed below.
Proposed Collection: Collection of
Grants and Contracts data the
Historically Black Colleges and
Universities (HBCUs) and small
businesses may be interested in
pursuing, 0925–0767, exp., date, 01/31/
2024, Office of the Director, Office of
Acquisitions and Logistics Management,
Small Business Program Office, National
Institutes of Health.
Need and Use of Information
Collection: Presidential Executive Order
13779 is the White House Initiative to
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
responses per
respondent
Average
burden per
response
(in hours)
Total annual
burden hour
Type of respondent
HBCU Pre-Solicitation Portal for Contracts and
Grants (Attachment Number 1).
Application for Small Business (Attachment Number 5).
Application for Universities (Attachment Number
4).
Private Sector ...............
62
18
45/60
837
Private Sector ...............
43
1
45/60
32
Private Sector ...............
19
1
45/60
14
Total ...............................................................
.......................................
62
1178
........................
883
Dated: January 23, 2024.
Lawrence A. Tabak,
Principal Deputy Director, National Institutes
of Health.
[FR Doc. 2024–01698 Filed 1–26–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HOMELAND
SECURITY
Federal Emergency Management
Agency
ddrumheller on DSK120RN23PROD with NOTICES1
Number of
respondents
Form name
[Docket ID FEMA–2024–0002]
Final Flood Hazard Determinations
Federal Emergency
Management Agency, Department of
Homeland Security.
ACTION: Notice.
AGENCY:
VerDate Sep<11>2014
18:33 Jan 26, 2024
Jkt 262001
Flood hazard determinations,
which may include additions or
modifications of Base Flood Elevations
(BFEs), base flood depths, Special Flood
Hazard Area (SFHA) boundaries or zone
designations, or regulatory floodways on
the Flood Insurance Rate Maps (FIRMs)
and where applicable, in the supporting
Flood Insurance Study (FIS) reports
have been made final for the
communities listed in the table below.
The FIRM and FIS report are the basis
of the floodplain management measures
that a community is required either to
adopt or to show evidence of having in
effect in order to qualify or remain
qualified for participation in the Federal
Emergency Management Agency’s
(FEMA’s) National Flood Insurance
Program (NFIP).
SUMMARY:
PO 00000
Frm 00072
Fmt 4703
Sfmt 4703
The date of June 6, 2024 has
been established for the FIRM and,
where applicable, the supporting FIS
report showing the new or modified
flood hazard information for each
community.
DATES:
The FIRM, and if
applicable, the FIS report containing the
final flood hazard information for each
community is available for inspection at
the respective Community Map
Repository address listed in the tables
below and will be available online
through the FEMA Map Service Center
at https://msc.fema.gov by the date
indicated above.
FOR FURTHER INFORMATION CONTACT: Rick
Sacbibit, Chief, Engineering Services
Branch, Federal Insurance and
Mitigation Administration, FEMA, 400
C Street SW, Washington, DC 20472,
ADDRESSES:
E:\FR\FM\29JAN1.SGM
29JAN1
]]>Agencies
[Federal Register Volume 89, Number 19 (Monday, January 29, 2024)]
[Notices]
[Pages 5550-5551]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-01698]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Submission for OMB Review; 30-Day Comment Request
Collection of Grants and Contracts Data the Historically Black
Colleges and Universities (HBCUs) and Small Businesses May Be
Interested in Pursuing (Office of the Director)
AGENCY: National Institutes of Health, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: In compliance with the Paperwork Reduction Act of 1995, the
National Institutes of Health (NIH), Office of the Director, Office of
Acquisitions and Logistics Management (OALM), Small Business Program
Office (SBPO), has submitted to the Office of Management and Budget
(OMB) a request for review and approval of the information collection
listed below.
DATES: Comments regarding this information collection are best assured
of having their full effect if received within 30-days of the date of
this publication.
ADDRESSES: Written comments and recommendations for the proposed
information collection should be sent
[[Page 5551]]
within 30 days of publication of this notice to www.reginfo.gov/public/do/PRAMain. Find this particular information collection by selecting
``Currently under 30-day Review--Open for Public Comments'' or by using
the search function.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the data collection plans and
instruments, contact: Keondra Watts, Program Analyst, NIH, Office of
the Director, Office of Acquisitions and Logistics Management, Small
Business Program Office, 6701 Rockledge Dr., Bethesda, MD 20892-7786,
or call non-toll-free number (301) 443-8722 or Email your request,
including your address to: [email protected].
SUPPLEMENTARY INFORMATION: This proposed information collection was
previously published in the Federal Register on October 27, 2023, pages
73864-73865 (88 FR 73864) and allowed 60 days for public comment. No
public comments were received. The purpose of this notice is to allow
an additional 30 days for public comment.
The National Institutes of Health (NIH), Office of the Director,
Office of Acquisitions and Logistics Management, Small Business Program
Office, may not conduct or sponsor, and the respondent is not required
to respond to any information collection that has been extended,
revised, or implemented on or after January 31, 2024, unless it
displays a currently valid Office of Management and Budget (OMB)
control number.
In compliance with Section 3507(a)(1)(D) of the Paperwork Reduction
Act of 1995, NIH has submitted to OMB a request for review and approval
of the information collection listed below.
Proposed Collection: Collection of Grants and Contracts data the
Historically Black Colleges and Universities (HBCUs) and small
businesses may be interested in pursuing, 0925-0767, exp., date, 01/31/
2024, Office of the Director, Office of Acquisitions and Logistics
Management, Small Business Program Office, National Institutes of
Health.
Need and Use of Information Collection: Presidential Executive
Order 13779 is the White House Initiative to Promote Excellence and
Innovation (PEI) of HBCUs. This Executive Order mandates agencies to
assist in strengthening HBCUs' ability for equitable participation in
federal programs and explore new ways to improve the relationship
between the federal government and HBCUs. This initiative will
establish how each agency intends to increase the capacity of HBCUs to
compete effectively for grants and contracts.
The PEI is a comprehensive plan to increase the capacity of HBCUs
as they pursue funding opportunities at the NIH. The PEI provides a
platform to increase transparency between HBCUs and the NIH by
promoting outreach events and training opportunities and providing
technical assistance. Currently, there are six HBCU participants and
each selected a minimum of one small business teaming partner to pursue
NIH funding opportunities with.
OMB approval is requested for 3 years. There are no costs to
respondents other than their time. The total estimated annualized
burden hours are 883.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Form name Type of Number of responses per per response Total annual
respondent respondents respondent (in hours) burden hour
----------------------------------------------------------------------------------------------------------------
HBCU Pre-Solicitation Portal Private Sector.. 62 18 45/60 837
for Contracts and Grants
(Attachment Number 1).
Application for Small Business Private Sector.. 43 1 45/60 32
(Attachment Number 5).
Application for Universities Private Sector.. 19 1 45/60 14
(Attachment Number 4).
---------------------------------------------------------------
Total..................... ................ 62 1178 .............. 883
----------------------------------------------------------------------------------------------------------------
Dated: January 23, 2024.
Lawrence A. Tabak,
Principal Deputy Director, National Institutes of Health.
[FR Doc. 2024-01698 Filed 1-26-24; 8:45 am]
BILLING CODE 4140-01-P
